(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MEDIGLYPHS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: Estados Unidos

Snapshot rápido

MEDIGLYPHS

ST13

US500000078416056

Classe

9, 16, 41

Pedido

78416056

Registro

3633096

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

58

Atualização mais recente

07/04/2023

Tipo de marca

Verbal

Classes Nice

9, 16, 41

Data de depósito

10/05/2004

Data de registro

02/06/2009

Data de expiração

-

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

23/05/2019

Última transação

07/04/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

800

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

16/09/2003

Primeiro uso no comércio

16/09/2003

Código do desenho

4

Tipo de titular

99

Localização do titular

COLUMBUS, OH, US

Examinador

JACKSON, STEVEN W

Unidade examinadora

L70

Localização atual

GENERIC WEB UPDATE

Titulares e representantes

Titulares

N. H. (pessoa física)
T. H. (pessoa física)

Representantes

Laura T. Geyer Vorys, Sater, Seymour and Pease LLP

Classificação técnica

Classes Nice

Classe 9Classe 16Classe 41

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 9

computer software that facilitates the communication of pharmaceuticalmedical and healthcare information to the general public by rendering the information in a manner that is broadly comprehendible to people of varying levels of literacy for use in the pharmaceuticalmedical and healthcare fields; computer software that facilitates the writing of prescriptions in the pharmaceuticalmedical and healthcare fields; educational computer software featuring instruction in the pharmaceuticalmedical and healthcare fields

Classe 16

printed instructional material for use in the design and teaching of literacy and communication classestraining programs and seminars by pharmaceuticalmedical and healthcare professionals; printed materialseducational hand-outsresearch reports and studies used to facilitate the communication of information between pharmaceuticalmedical and healthcare professionals and the general public

Classe 41

educational servicesoffering classestraining programs and seminarsin the pharmaceuticalmedical and healthcare fields and distributing course materials in connection therewith

Publicações

Histórico de despachos e eventos da marca no USPTO.

58 publicações encontradas

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

23/05/2019

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

23/05/2019

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

23/05/2019

E89R

TEAS SECTION 8 & 9 RECEIVED

17/05/2019

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

02/06/2018

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

15/04/2016

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

15/04/2016

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

05/02/2016

C15P

REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

05/02/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/02/2016

E815

TEAS SECTION 8 & 15 RECEIVED

30/11/2015

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/02/2012

R.PR

REGISTERED-PRINCIPAL REGISTER

02/06/2009

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

28/04/2009

ALIE

ASSIGNED TO LIE

28/04/2009

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

28/04/2009

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

24/04/2009

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

23/04/2009

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/04/2009

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

23/04/2009

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

31/10/2008

GNRT

NON-FINAL ACTION E-MAILED

31/10/2008

CNRT

SU - NON-FINAL ACTION - WRITTEN

31/10/2008

SUPC

STATEMENT OF USE PROCESSING COMPLETE

20/10/2008

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

20/10/2008

IUAF

USE AMENDMENT FILED

17/10/2008

EISU

TEAS STATEMENT OF USE RECEIVED

17/10/2008

EX5G

SOU EXTENSION 5 GRANTED

03/06/2008

TPEX

SOU EXTENSION RECEIVED WITH TEAS PETITION

28/05/2008

PETG

PETITION TO REVIVE-GRANTED

28/05/2008

PROA

TEAS PETITION TO REVIVE RECEIVED

28/05/2008

EXT5

SOU EXTENSION 5 FILED

18/04/2008

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

12/12/2007

EX4G

SOU EXTENSION 4 GRANTED

26/10/2007

EXT4

SOU EXTENSION 4 FILED

17/10/2007

EEXT

SOU TEAS EXTENSION RECEIVED

17/10/2007

EX3G

SOU EXTENSION 3 GRANTED

17/04/2007

EXT3

SOU EXTENSION 3 FILED

17/04/2007

EEXT

SOU TEAS EXTENSION RECEIVED

17/04/2007

EX2G

SOU EXTENSION 2 GRANTED

02/11/2006

EXT2

SOU EXTENSION 2 FILED

29/09/2006

EEXT

SOU TEAS EXTENSION RECEIVED

29/09/2006

EX1G

SOU EXTENSION 1 GRANTED

11/05/2006

EXT1

SOU EXTENSION 1 FILED

18/04/2006

MAIL

PAPER RECEIVED

18/04/2006

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

18/10/2005

PUBO

PUBLISHED FOR OPPOSITION

26/07/2005

NPUB

NOTICE OF PUBLICATION

06/07/2005

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

25/03/2005

ALIE

ASSIGNED TO LIE

25/03/2005

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/03/2005

ACEC

AMENDMENT FROM APPLICANT ENTERED

02/03/2005

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

31/01/2005

MAIL

PAPER RECEIVED

31/01/2005

GNRT

NON-FINAL ACTION E-MAILED

09/12/2004

CNRT

NON-FINAL ACTION WRITTEN

09/12/2004

DOCK

ASSIGNED TO EXAMINER

08/12/2004

NWAP

NEW APPLICATION ENTERED

18/05/2004

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MEDIGLYPHS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.